Reporting of hospital infection rates and burden of C. difficile

July 17, 2012

A new study published today in PLoS Medicine re-evaluates the role of public reporting of hospital-acquired infection data.

The study, conducted by Nick Daneman and colleagues, used data from all 180 acute care hospitals in Ontario, Canada. The investigators compared the rates of infection of Clostridium difficile colitis prior to, and after, the introduction of public reporting of ; public reporting was associated with a 26% reduction in C. difficile cases.

The authors comment "This longitudinal population-based cohort study has confirmed an immense burden of in Ontario, while heralding mandatory hospital reporting as one potential means to reduce this burden".

Explore further: Study reports increasing incidence of Clostridium difficile infection

More information: Daneman N, Stukel TA, Ma X, Vermeulen M, Guttmann A (2012) Reduction in Clostridium difficile Infection Rates after Mandatory Hospital Public Reporting: Findings from a Longitudinal Cohort Study in Canada. PLoS Med 9(7): e1001268. doi:10.1371/journal.pmed.1001268

Related Stories

C. difficile lengthens hospital stays by 6 days

December 5, 2011

A new study published in the CMAJ (Canadian Medical Association Journal) reports that hospital-acquired Clostridium difficile infection increases length of stay in hospital by an average of six days.

Recommended for you

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.